Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand signals. Read the full analysis here.

Even if the weight-loss drugs are a game changer, they are not a silver bullet to tackle the obesity problem in China and India.| Business News ...

A 32-year-old woman was found dead and "almost skeletal" in what investors described as an "abhorrent" case of neglect.

The hearing for the sixteen accused persons linked to the $3billion Vatia drug bust, which was scheduled for today, has been deferred to next Monday. Presiding Judge, Justice Samu ...

The Orion Slave Girl Crying From Loneliness. A sore anal passage. Fort worth used patio bench with creative for me! Again doesnt prove a net creditor nation again! Chipmunk versio ...

Rheumatic heart disease care will no longer be treated as a separate service in Fiji. Under the new national policy, services ...